帕金森病认知障碍的病理生物学:挑战和前景
1Institute of Clinical Neurobiology, Alberichgasse 5/13, A-1150 Vienna, Austria.
International journal of molecular sciences
|January 11, 2024
概括
帕金森病 (PD) 的认知障碍涉及大脑网络变化和蛋白质病理. 了解这些机制对于早期诊断和开发PD认知障碍新疗法至关重要.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 病理生物学 病理生物学
背景情况:
- 认知障碍 (CI) 是帕金森病 (PD) 的一个显著的非运动症状,在20年内影响高达83%的患者.
- 在25%的PD患者中,早期诊断显示轻度CI,突出了认知缺陷的渐进性质.
- PD-CI的病理生物学是复杂的,涉及多巴氨基系统退化和广泛的神经网络功能障碍.
研究的目的:
- 探索帕金森病中认知障碍的复杂病理生物学.
- 研究神经成像和神经病理相互作用在PD-CI中的作用.
- 确定用于早期诊断和潜在的疾病修饰疗法的生物标志物.
主要方法:
- 利用现代神经成像检测皮层/皮下缩和改变的神经连接.
- 分析功能连接 (FC) 的变化,特别是在默认模式网络 (DMN),甚至在临床CI之前.
- 检查认知衰退,脑损伤,网络改变和蛋白质病理 (α-synuclein,tau,β-amyloid) 之间的纵向关联.
主要成果:
- 在DMN的前额叶皮层中减少FC发生在PD-CI的早期,独立于结构变化.
- 纵向认知衰退与前,边缘和其他神经网络的疾病相关.
- α-synuclein,tau和β-amyloid之间的相互作用有助于PD的痴呆和勒维体痴呆 (DLB) 的痴呆.
结论:
- PD-CI涉及渐进的结构和功能性大脑变化,包括网络改变.
- 在PD中早期发现CI需要复杂的生物标志物来了解潜在的病理.
- 进一步的纵向研究对于开发PD-CI的有效诊断工具和疾病修饰治疗方法至关重要.
相关概念视频
01:15Parkinson's Disease: Overview
551
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
551
01:26Alzheimer's Disease: Overview
490
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
490
01:24Parkinson's Disease: Treatment
272
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
272
01:30Dementia
115
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
115
01:22Alzheimer's Disease: Treatment
195
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
195
01:27Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders
657
Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...
657